Latterell Venture Partners
Latterell Venture Partners invests in early stage healthcare companies with innovative technologies, large market opportunities, and passionate entrepreneurs. We offer a unique blend of venture capital, entrepreneurial, technical, clinical and collaborative skills which enable us to help entrepreneurs create highly successful new startups. LVP is committed to building a portfolio of outstanding biotechnology and medical device companies which produce excellent returns for our limited partners while providing major new disease treatments to help patients worldwide.
Milestones
Investments
Videos
Sources
-
Neuraltus Pharmaceuticals, Inc.: Series B $9.6M (onbiovc.com)
[edit]
-
Transcend Medical, Inc.: Series B $16M (onbiovc.com)
[edit]
-
Inova Labs Closes on $17.5M Series B Financing (money.msn.com)
[edit]
-
Naurex raises $18M for Ph2 depression program (fiercebiotech.com)
[edit]
-
Cell Biosciences Nabs $20M (xconomy.com)
[edit]
-
Femta Pharmaceuticals, Inc.: Series A $22M (onbiovc.com)
[edit]
-
TetraLogic nabs $32M round for lead cancer therapy Read more: TetraLogic nabs $32M round for lead cancer therapy (fiercebiotech.com)
[edit]
-
Calistoga Pharmaceuticals Raises $40 Million in Series C Financing (calistogapharma.com)
[edit]
-
Pulmonx, Inc.: Series C $32M (onbiovc.com)
[edit]
-
Femta Pharmaceuticals Raises $1M (socaltech.com)
[edit]
-
Transcend Medical pockets $35M in VC (fiercebiotech.com)
[edit]
-
Cell Biosciences Raises $10 Million (pehub.com)
[edit]
-
Neuraltus Pharmaceuticals Raises $17 Million Series A Funding (neuraltus.com)
[edit]
-
Pathway Medical lands generous $40M to treat arterial disease (venturebeat.com)
[edit]
-
OncoMed Pharmaceuticals, Inc. Completes $154 Million Series B Financing (biospace.com)
[edit]
-
Talima Therapeutics raises $19M for site-specific drugs (venturebeat.com)
[edit]
-
Lung-device maker Pulmonx draws in $20M (venturebeat.com)
[edit]
-
Ovalis, Inc.: Series B $6.6M (onbiovc.com)
[edit]
-
Bio-Medicine (bio-medicine.org)
[edit]